PPARα and PPARγ are recognized as potentially important players in immunomodulation and anti-inflammatory regulation in different inflammatory disorders including pulmonary diseases such as COPD and asthma [6]. This evidence concerns the gene PPARG and chronic obstructive pulmonary disease.